Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Ocean Power Technologies, Inc. has achieved Cybersecurity Maturity Model Certification (CMMC) Level 2 compliance, strengthening its ability to support U.S. Department of War contracts and other federal programs requiring secure handling of controlled unclassified information. This milestone enhances OPT's competitiveness in the defense sector as it…
Patria Investments Limited will release its second quarter 2026 financial results on July 31, 2026, followed by a public webcast investor call. As a global alternative asset manager with a strong presence in Latin America, Europe, and the U.S., Patria specializes in resilient mid-market sectors including infrastructure, credit, real estate, and pri…
HII, a leading U.S. defense shipbuilder, announced a quarterly cash dividend of $1.38 per share payable on September 11, 2026. This dividend reflects the company's strong financial position and ongoing commitment to returning value to shareholders.
Shares of Bausch + Lomb climbed in pre-market trading after the company reported second-quarter 2026 results that beat revenue expectations, matched adjusted EPS estimates, and prompted an upward revision to full-year revenue guidance. The quarter also featured a material swing to operating profitability and a large increase in operating cash flow,…
Belite Bio (BLTE) is a clinical-stage biotech with a differentiated oral candidate, tinlarebant, that completed a rolling NDA submission for Stargardt disease type 1 and has Phase 3 data showing a meaningful clinical effect. The company has near-term regulatory catalysts, a healthy cash position, and clear commercialization preparation. This trade …
Alpha Modus Holdings, a NASDAQ-listed AI-driven technology company, announced an expanded corporate development strategy to evaluate acquisitions, partnerships, and business combinations. The company aims to leverage its core technologies in AI, fintech, and retail innovation to enhance long-term shareholder value by pursuing complementary high-gro…
VivoPower PLC announced a $50 million private investment in public equity (PIPE) led by Blue Sky Capital, aimed at funding operational expansion of its AI data center in Mo i Rana, Norway, and reducing corporate debt. The raise attracted a diverse group of US, European, Nordic, and Gulf-based institutional investors, strengthening the company's fin…
Uniper has finalized a 20-year liquefied natural gas purchase agreement with Canada that secures 2 million tonnes per year from the Ksi Lisims LNG project starting in 2032. The contract builds on an earlier June understanding and follows related long-term deals by other German importers as Europe seeks alternatives to Russian pipeline gas.
Quantum X Labs Inc. has successfully demonstrated an end-to-end quantum-enabled clinical data analysis use case using real-world clinical data within its proprietary quantum simulation environment. The achievement highlights the operational capability of their integrated platform to process clinical data through preparation, analysis and interpreta…
CBIZ, Inc. reported its second-quarter and first-half 2026 financial results with stable revenue but lower net income in Q2 and growth for the first half of the year. The company successfully executed an enterprise-wide AI rollout and expanded its talent base. Separately, CBIZ entered a definitive merger agreement with Grant Thornton valued at $5 b…
Candel Therapeutics, a clinical-stage biopharmaceutical firm developing multimodal immunotherapies for cancer, announced it will present at the upcoming Canaccord Genuity 46th Annual Growth Conference in Boston. The company highlighted its lead product candidates, aglatimagene besadenovec and linoserpaturev, with ongoing and completed clinical tria…
Global-e Online Ltd., a global e-commerce enablement platform, announced it will report its financial results for the second quarter ended June 30, 2026, before market open on August 12, 2026. A conference call and webcast will be held to discuss the results and outlook.
Fluent, Inc., a commerce media solutions provider, announced it will release its second quarter 2026 financial results after market close on August 10, 2026, followed by a conference call to discuss the results. The call will be accessible via phone registration and webcast on the company's Investor Relations webpage.
Fuel Tech, Inc. announced the award of two air pollution control contracts totaling approximately $2.6 million with domestic industrial customers. The contracts include the supply of Selective Catalytic Reduction (SCR) systems and an accelerated SCR project delivery. These contracts contribute to Fuel Tech's $12.6 million in bookings so far in 2026…
Kaltura has been named a Leader in the 2026 IDC MarketScape for Worldwide Virtual Events Applications, highlighting its advanced platform that enhances engagement, interaction, and data-driven insights for virtual events. The company’s AI-driven features, including conversational avatars and content intelligence, position it strongly in the enterpr…
NewAmsterdam Pharma announced it will host an Investor Day on August 5, 2026, to provide updates on its late-stage clinical development of obicetrapib, an oral CETP inhibitor aimed at patients with elevated LDL cholesterol at risk for cardiovascular disease. The event will feature management presentations and live webcast availability. Obicetrapib …
DoubleVerify released a global study revealing that consumer and marketer acceptance of AI in digital advertising hinges on the quality and context of AI-generated content rather than AI usage itself. While consumers globally show optimism toward AI-powered online experiences, concerns increase with low-quality AI ads and contextual relevance. Mark…
Akebia Therapeutics plans to report its second quarter financial results for 2026 on August 5, 2026, with a subsequent conference call to discuss the results and recent business highlights. The company is a biopharmaceutical firm focused on kidney disease and is based in Cambridge, Massachusetts.
Liberty Defense Holdings Ltd. announced the issuance of 23,306 common shares at $4.55 per share to settle CAD$117,000 of debt related to its U.S. IPO and Nasdaq listing expenses. The issued shares are subject to a statutory hold period, and the company emphasized compliance with U.S. securities laws. Liberty Defense specializes in AI-based security…
UroGen Pharma Ltd. will report its financial results for the second quarter of 2026 on August 5th, 2026, prior to market open. The company will host a live audio webcast and conference call to discuss the results. UroGen is focused on developing innovative therapies for urothelial and specialty cancers using its proprietary RTGel sustained-release …
Filana Therapeutics reported a net loss of $8.6 million for Q2 2026, with cash reserves of $82.7 million. The company remains under a clinical hold by the FDA for its simufilam trial targeting TSC-related epilepsy but is actively engaging with the FDA and the TSC community. Financial metrics improved from prior year due to program phase-out and low…
Viasat, Inc., a leading global satellite communications company, announced it will release its Q1 fiscal year 2027 financial results on August 4, 2026. The company will host a webcast and conference call to discuss results. Since Q1 earnings announcements are routine, the market reaction is expected to be neutral unless new information significantl…
MediWound Ltd., a biotech company specializing in enzymatic therapies for tissue repair, will release its Q2 2026 financial results on August 13, 2026. The company will host a conference call and webcast to discuss the results and provide a corporate update. MediWound markets FDA-approved product NexoBrid for burn treatment and is developing Eschar…
LB Pharmaceuticals announced a $150 million private placement involving the sale of common stock and pre-funded warrants to institutional investors. The proceeds will primarily support pipeline expansion and ongoing clinical trials of LB-102, their lead investigational benzamide antipsychotic targeting schizophrenia and other neuropsychiatric disor…
Tevogen Bio Holdings Inc. has officially changed its name to Tevogen Inc. to better reflect its strategic evolution from a pure biotechnology company into a broader healthcare enterprise integrating biotech, AI technology, and healthcare services. Trading on Nasdaq under the same tickers (TVGN and TVGNW), the company aims to leverage these combined…
